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methacholine; calcium sensitivity; fura 2; protein kinase C; small G proteins ALTHOUGH AN INCREASE in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) plays an important role in the contraction of airway smooth muscle (7) , it is generally considered that muscarinic receptor agonists and histamine increase tension at a constant [Ca 2ϩ ] i . This phenomenon is referred to as Ca 2ϩ sensitization (31) and is mediated by a GTP-binding (G) protein-coupled mechanism (14, 15) . Because hyperreactivity to these agonists is a hallmark of bronchial asthma, an increase in sensitivity to intracellular Ca 2ϩ may be involved in the pathophysiology of this disease (3) . Muscarinic receptor agonists cause a transient increase in [Ca 2ϩ ] i mediated by Ca 2ϩ release from the sarcoplasmic reticulum by inositol 1,4,5-trisphosphate production (9), followed by a reduction in sustained [Ca 2ϩ ] i level that is higher than the control level (29) , indicating that Ca 2ϩ sensitization may be involved in tonic contraction. However, because airway contraction with carbachol is not sustained in the absence of Ca 2ϩ on the extracellular side (1), it is generally considered that Ca 2ϩ influx is also needed to produce tonic contraction. Not only Ca 2ϩ sensitization but also Ca 2ϩ mobilization may be involved in contraction induced by various receptor agonists.
It has been revealed that RhoA, a small monomeric G protein, enhances sensitivity to Ca 2ϩ by affecting myosin light chain processes in smooth muscle (6, 8, 10) , including that in the airways (4) . Recently, it was found that Rho-associated protein kinase (Rho kinase), which is a target protein of RhoA (12, 13, 25) , inhibits myosin light chain phosphatase (MLCP) activity. Y-27632, a selective Rho kinase inhibitor (34) , effectively decreases Ca 2ϩ sensitivity mediated by various agonists such as carbachol, histamine, phenylephrine, and endothelin-1 under the condition of a constant [Ca 2ϩ ] i with skinned fiber from smooth muscle (34, 35) . The effects of Y-27632 were mimicked by Clostridium botulinum C3 toxin (4) and Clostridium difficile toxin B (22) , direct inhibitors of Rho proteins. Therefore, it is now appreciated that the inhibition of MLCP activity through the Rho/Rho kinase pathway is the main mechanism of Ca 2ϩ sensitization (32) . Although permeabilized preparations that allow control of [Ca 2ϩ ] i have been commonly used to characterize Ca 2ϩ sensitivity, a loss of proteins and ions important for contraction cannot be excluded during the permeabilization procedure by incubation with ␣-toxin or ␤-escin. In addition to this, the Ca 2ϩ -clamp technique is very beneficial in the research of Ca 2ϩ sensitization, whereas this method is not appropriate for analyzing the modification in [Ca 2ϩ ] i . Little is currently known about the effects of Rho/Rho kinase processes on the relationships between tension and [Ca 2ϩ ] i induced by agonists in intact (nonpermeabilized) smooth muscle.
In this study, to determine the role of Ca 2ϩ sensitization and Ca 2ϩ mobilization in muscarinic receptor stimulation, we analyzed relationships between ten-sion and [Ca 2ϩ ] i regulated by Rho/Rho kinase processes using intact guinea pig tracheal smooth muscle.
METHODS
Tissue preparation and isometric tension records. The methods are essentially similar to those previously described (19, 20, 30) . Male guinea pigs (250-350 g) were killed by stunning and bleeding, and the tracheae were excised. The tracheal rings were opened by cutting longitudinally at the cartilaginous region, and the epithelium was dissected out. Segments containing one cartilaginous ring (for isometric tension recording) and two cartilaginous rings (for [Ca 2ϩ ]i measurements) were prepared. The strip was 1.5-2.0 mm in width by 4.5-5.0 mm in length and 0.3-0.4 mg in wet weight at each cartilaginous lesion. A preparation was placed horizontally in an organ bath (0.6-ml volume). One end of the segment was fixed to the chamber, and the other end was connected to a force displacement transducer to monitor isometric tension. After the initial response to 1 M methacholine (MCh) was recorded, the experiments were started, and an equimolar concentration of MCh was applied at the end of each experiment to determine whether the strips were constantly equilibrated. The normal bathing solution was composed of (in mM) 137 NaCl, 5.9 KHCO 3, 2.4 CaCl2, 1.2 MgCl2, and 11.8 glucose and bubbled with a mixture of 99% O2 and 1% CO2 (pH 7.4). The normal bathing solution was perfused to the organ bath at a constant flow of 3 ml/min. The spontaneous tone was abolished by the addition of 2 M indomethacin throughout the experiments. The temperature of the organ bath was maintained at 37°C.
Measurement of fura 2 fluorescence. Muscle strips were treated with 10 M fura 2-AM for 4 h at room temperature (22-24°C). The noncytotoxic detergent pluronic F-127 (0.01% wt/vol) was added to increase the solubility of fura 2-AM. After the loading, the chamber was perfused with the normal solution at 37°C for 50 min to wash out the extracellular fura 2-AM before the measurements. Isometric tension and fura 2 fluorescence of the muscle strips were measured simultaneously with a displacement transducer and a spectrofluorometer (CAF-110, Japan Spectroscopic, Tokyo, Japan). The method for the measurement of [Ca 2ϩ ]i was as previously described (30) . The mucosal side of the muscle strips was exposed to the excitation light, and the light emitted from the strip was collected into a photomultiplier through a 500-nm filter. The intensities of fluorescence due to excitation at 340 (F340) and 380 (F380) nm were measured after background subtraction. The absolute amount of [Ca 2ϩ ]i was not calculated because the dissociation constant of fura 2 for Ca 2ϩ in smooth muscle cytoplasm may be different from that obtained in vitro (16) . Therefore, the ratio of F340 to F380 (F340/F380) is used as a relative indicator of [Ca 2ϩ ]i. Because force generation with an identical concentration of MCh varied with each strip, the effects of agents are also expressed by percent normalization. Measurements of tension and F340/F380 were made when the muscle contraction had attained a steady state. Muscle tension and F340/F380 in the resting state were taken as 0%, and the values for percent contraction and F340/F380 were calculated by taking the responses to 0.1 and 1 M MCh in the control tissues as 100%. Time-matched control tissues were treated similarly to the test tissues but were exposed to the normal bathing solution instead of Y-27632 (see Fig. 2 ).
Materials. MCh, indomethacin, nifedipine, pluronic F-127, and 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide (GF-109203X) were obtained from Sigma (St. Louis, MO). Phorbol-12,13-dibutyrate was from Calbiochem (La Jolla, CA). Fura 2-AM was obtained from Dojin Laboratories (Kumamoto, Japan).
dihydrochloride, monohydrate (Y-27632) was a gift from Welfide (Osaka, Japan). Fura 2-AM was dissolved in DMSO, and the final DMSO concentration did not exceed 0.5%. Y-27632 was dissolved in distilled water as stock solution (100 mM), and stored at Ϫ20°C. Neither solvent affected muscle tension or fluorescence ratio.
Statistical analysis. All data are expressed as means Ϯ SE; n is the number of preparations used. Student's unpaired t-test was used to evaluate the significance of differences between means, with P Ͻ 0.05 as the level of significance. ] i , tension-F340/F380 curves for MCh with Y-27632 were calculated from the data shown in Fig. 1B (Fig. 1C) . The curves did not shift markedly between 0.1 and 1.0 M MCh (Fig. 1C) . Y-27632 caused an ϳ50% inhibition of the MCh-induced contraction, with no change in F340/F380 at each concentration of MCh between 0.1 and 1 M. However, this agent caused further inhibition, with a reduction in [Ca 2ϩ ] i (Fig. 1C) . (Fig. 3A) . Figure 3B shows that the percent contraction and percent F340/ were additive, indicating that a reduction in [Ca 2ϩ ] i with Y-27632 was not affected by nifedipine.
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2ϩ sensitization. To determine the involvement of protein kinase (PK) C on MCh-induced Ca 2ϩ sensitization, the inhibitory action of Y-27632 on MCh-induced contraction was examined in the presence of GF-109203X, a membrane-permeable inhibitor of PKC (33) . MCh (1 M) was applied to the fura 2-loaded strips for 10 min, and after washout for 5 min, 5 M GF-109203X was perfused. After incubation with GF-109203X for 30 min, 1 M MCh was again applied to the identical tissues, and then 10 M Y-27632 was applied (Fig. 4A) . A significant reduction in tension and F340/F380 with 1 M MCh did not occur in the presence of 5 M GF-109203X (Fig. 4, B and C) . Moreover, subsequent application of 10 M Y-27632 caused a reduction in tension produced with 1 M MCh in the presence of 5 M GF-109203X (Fig. 4A) . The percent contraction for MCh with Y-27632 in the presence and absence of GF-109203X was 63.0 Ϯ 4.0 (n ϭ 5) and 60.5 Ϯ 6.0% (not significant; n ϭ 5), respectively (Fig. 4B) , whereas the percent F340/F380 for MCh with Y-27632 in the presence and absence of GF-109203X was 91.5 Ϯ 5.6 (n ϭ 5) and 90.6 Ϯ 7.1% (not significant; n ϭ 5), respectively (Fig. 4C) . GF-109203X did not affect tension or F340/F380 regulated with Y-27632.
DISCUSSION
This study demonstrates for the first time the effects of inhibition of Rho kinase on tension and [Ca 2ϩ ] i induced by a muscarinic receptor agonist in airway smooth muscle. Previous reports (6, 13, 34, 35) have demonstrated that inactivation of MLCP by Rho kinase leads to agonist-induced Ca 2ϩ sensitization. When Y-27632 is cumulatively applied to permeabilized tissues under the condition of Ca 2ϩ clamp, this agent inhibited agonist-and guanosine 5Ј-O-(2-thiotriphos- phate)-induced Ca 2ϩ sensitization in various types of smooth muscle in a concentration-dependent manner (5, 11, 34, 35) . Based on a previous report (29) with intact fura 2-loaded smooth muscle, we examined the relationship between tension and [Ca 2ϩ ] i induced by MCh to evaluate the change in Ca 2ϩ sensitization by Y-27632 (Fig. 2) . The tension-F340/F380 curves for MCh (0.01-10 M) were shifted to the right in the presence of 10 M Y-27632, indicating that an inhibition of Rho kinase inhibits MCh-induced Ca 2ϩ sensitization (Fig. 2B) . However, when the concentration of MCh was lowered to 0.01 M, 10 M Y-27632 caused a reduction in [Ca 2ϩ ] i with relaxation, indicating that inhibition of Rho kinase may affect Ca 2ϩ mobilization. In intact smooth muscle, Y-27632 also caused a roughly complete relaxation of agonist-induced contraction of vascular (34) and tracheal (35) smooth muscle in rabbits. In this study, Y-27632 inhibited MChinduced contraction in guinea pig tracheal smooth muscle similar to these previous observations (Fig. 1) . However, Y-27632 caused a reduction in F340/F380, with relaxant effects in a concentration-dependent manner (Fig. 1) . Our results not only support the idea that inhibition of Rho kinase activity leads to inhibition of agonist-induced contraction via a reduction in Ca 2ϩ sensitivity, but they also suggest that the Rho/ Rho kinase pathway affects intracellular Ca 2ϩ mobilization.
To determine the involvement of Rho kinase in Ca ] i curves were examined under the condition that Y-27632 was cumulatively applied to the tissues in the presence of 0.1 and 1 M MCh (Fig. 1, B and C) . In guinea pig tracheal smooth muscle, 10 M MCh produces a roughly 100% contraction, and the percent contraction for 0.1 and 1 M MCh was ϳ40 and 80%, respectively (19) . These concentrations are appropriate to investigate muscarinic stimulation without side effects. Because concentrations of Y-27632 Ͻ 10 M caused up to an ϳ50% inhibition of 1 M MCh-induced contraction, with little change in [Ca 2ϩ ] i , a reduction in Ca 2ϩ sensitivity by the Rho/Rho kinase pathway is involved in the relaxant effects of this agent (Fig. 1, B and C) . On the other hand, higher concentrations of Y-27632 caused further relaxation, with a reduction in [Ca 2ϩ ] i in a concentration-dependent manner. The inhibition constant (K i ) value of Y-27632 for inhibiting Rho kinase is generally considered to be 0.14 M in vitro (34) . Y-27632 at 10 M, a concentration close to the K i value for Rho kinase inhibition, caused relaxation, with a reduction in F340/ F380 in guinea pig tracheal smooth muscle when MCh was lowered to 0.1 M (Fig. 1, B and C) . Moreover, application of HA-1077, another inhibitor of Rho kinase (34) , caused inhibition of MCh-induced contraction, with a reduction in F340/F380 in guinea pig tracheal smooth muscle similar to that with Y-27632 (Ito, unpublished observations (Fig. 4) . These results indicate that PKA and PKC are not involved in Ca 2ϩ mobilization induced with Y-27632. A reduction in [Ca 2ϩ ] i by concentrations of Y-27632 Ͼ100 M may be mediated by nonspecific effects.
Because the physiological role of PKC in agonistinduced Ca 2ϩ sensitization is still controversial in permeabilized tissues of tracheal smooth muscle (2, 11), we examined the involvement of PKC in Ca 2ϩ sensitization in intact tissues. PKC represents a family of various lipid-dependent serine/threonine kinases that can be divided into three categories: conventional PKC (cPKC), novel PKC (nPKC) and atypical PKC (aPKC) (28) . As shown in Fig. 4 , the inhibitory effects of 10 M Y-27632 on tension and F340/F380 by 1 M MCh were not affected in the presence of 5 M GF-109203X, an inhibitor of cPKC and nPKC (33) . Moreover, 5 M GF-109203X did not change tension and F340/F380 with 1 M MCh. Because incubation with 5 M GF-109203X for 30 min completely the blocked contraction with 2.5 M phorbol-12,13-dibutyrate, GF-109203X acts as a PKC inhibitor (Ito, unpublished observations). Under the condition of intracellular application, GF-109203X inhibits cPKC and nPKC, with an EC 50 value of 0.2 M, and this agent also inhibits aPKC, with an EC 50 value of 5.7 M (23). This agent at 5 M is considered to be sufficient to inhibit cPKC and nPKC. Our results indicate that these PKC subtypes (cPKC and nPKC) are involved neither in Ca 2ϩ sensitization by Rho kinase nor in the contraction induced by muscarinic stimulation in intact guinea pig tracheal smooth muscle. However, PKC-induced contraction is considered to be mediated by many pathways such as Ca 2ϩ sensitization, myosin light chain phosphorylation (24), Ca 2ϩ influx (27) , and the inhibition of MLCP (21) . PKC inhibitors do not necessarily antagonize all the mechanisms. A possible role of aPKC in Ca 2ϩ sensitization could not be excluded by the results of this study. Further experiments are required to determine the involvement of PKC in contraction and Ca 2ϩ sensitization by muscarinic stimulation.
It is well known that tension development is not always consistent with an increase in [Ca 2ϩ ] i between high K ϩ -and carbachol-induced contraction (29) . Because high K ϩ -induced contraction is completely abolished by an inhibitor of VDCCs, this contraction may be mediated by an increase in [Ca 2ϩ ] i via Ca 2ϩ influx through VDCCs. On the other hand, because a VDCC inhibitor does not cause a marked inhibition against contraction induced by agonists such as MCh, histamine, and eicosanoids, contraction induced by these agents may be involved in mechanisms other than VDCCs (26) . As shown in Fig. 3A , 1 M nifedipine caused a modest inhibition of 1 M MCh-induced contraction, with a marked reduction in F340/F380. MCh caused an increase in VDCCs via membrane depolarization by an inactivation of large-conductance Ca 2ϩ -activated K ϩ channels (18); however, this process makes a modest contribution to the contraction induced by 1 M MCh. In single-channel records, VDCCs are completely inhibited by 0.1-10 M nifedipine (17) . Because 10 M Y-27632 did not attenuate [Ca 2ϩ ] i induced by 1 M MCh (Fig. 1A) , 100 M (10-fold concentration) was applied in the presence of 1 M nifedipine to examine involvement of VDCCs in the reduction in [Ca 2ϩ ] i with Y-27632 (Fig. 3) . Y-27632 caused a reduction in [Ca 2ϩ ] i even though VDCCs were fully suppressed by 1 M nifedipine (Fig. 3B) . These results indicate that a reduction in [Ca 2ϩ ] i with Y-27632 may not be mediated by VDCCs and an increase in sensitivity to Ca 2ϩ with Rho kinase may play an important role in agonist-induced contraction.
In conclusion, the Rho/Rho kinase process is involved in Ca 2ϩ sensitization and may be involved in Ca 2ϩ mobilization induced by muscarinic activation in intact airway smooth muscle. Our results provide evidence that inhibition of Rho kinase may beneficial to improvement of bronchial hyperreactivity.
